Hab Pharmaceutical and Research Limited v. Matish Healthcare Private Limited
Case brief
What is this about?
Trademark infringement; amendment of plaint; Order VI Rule 17 CPC; deceptively similar marks; TIGAMOL; EKTAMOL; TEKOMOL; SIGNATURE; execution of ad-interim order; Court Commissioner; Hab Pharmaceutical and Research Ltd v. Matish Healthcare Pvt Ltd; Bombay High Court Commercial Division; Commercial IP Suit No. 537 of 2025; 2025:BHC-OS:22195; ex parte hearing (defendant served, unrepresented); amendment within two weeks; ad-interim relief continued.
What did the court decide?
Permission to amend the plaint granted; amendment to be carried out within two weeks; application listed on 16th December, 2025; ad-interim relief granted earlier to continue till the next date. ¶21